LAC · Lithium Americas Corp.

The thesis

Lithium Americas' share-price recovery case remains broken: the shares closed at $2.16 on 27 October 2026, below the $2.25 level the earlier note named, with lithium prices weak and the Yorkville conversion floor of $1.63 still below the market. The third-quarter report, estimated for about 12 November 2026, settles whether spending, funding and the late-2027 completion date can support a rebuilt case.

The narrative is dead for the share price: the recovery story failed after the 18 September 2026 close of $2.86. The one-day gain of 6.93% on 27 October 2026, from $2.02 on 26 October 2026 (Morningstar quote), has not returned the shares to the $2.25 level. The project story is separate, because the company's 13 August 2026 update still targeted mechanical completion at Thacker Pass in late 2027.

Adjusted daily closes show a fall of 25.3% over three months to 27 October 2026, and a close 66.5% below the 52-week high of $6.44. Lithium Americas has no revenue until the Nevada plant is complete, so the shares trade on lithium prices, financing terms and construction news. Moving the rating up needs new evidence on those three, not a one-day bounce.

Bullish and bearish views on Lithium Americas Corp.

The bull case on Lithium Americas Corp. (LAC), in brief: Construction is advancing. The bear case: The recovery failed and has not been rebuilt.

Bull case

• Construction is advancing. The 13 August 2026 second-quarter release reported more than 1,600 workers on site, power energization targeted for the fourth quarter of 2026 and mechanical completion targeted for late 2027.
• Federal funding backs the build. The Department of Energy closed a $2.23 billion loan on 7 October 2025 and had advanced a cumulative $1.209 billion by 3 June 2026.
• Of that cash, $530.3 million sits inside the joint venture.
• Analyst targets sit far above the shares. JPMorgan rated the shares Overweight with a $6.00 target, reported by StreetInsider on 9 September 2026. Aggregated targets run from $4.00 to $6.00 with an average of $5.00, so the shares trade well under every published target.

Bear case

• The recovery failed and has not been rebuilt. The shares closed at $2.86 on 18 September 2026 and $2.07 on 14 October 2026. Morningstar lists a 52-week low of $1.98, and the 27 October 2026 close of $2.16 is still under $2.25.
• Lithium prices are weak. GuruFocus reported that lithium carbonate futures on the Guangzhou Futures Exchange fell 11.8% on 12 October 2026, the largest daily drop since March, on oversupply concerns. Trading Economics showed lithium at 108,250 yuan per tonne on 14 October 2026, down 20.32% over a month.
• Dilution rises as the price falls. Yorkville debentures convert at the lower of a fixed price or 95% of the lowest five-day average price, floored at $1.63. At $2.16 the floor is not binding, so each conversion issues more shares than it would at a higher price.
• Equity supply is registered. The company agreed a $175 million Yorkville facility on 5 August 2026 and raised $72.7 million net through its at-the-market program through August.
• Heavy spending is still ahead. Cumulative capitalized spending was $1.8 billion at 30 June 2026, with $1.6 billion counted toward the $2.93 billion Phase 1 estimate. Revenue does not start until after the late-2027 completion.

Price setup

Adjusted daily closes fell from $2.86 on 18 September 2026 to $2.57 on 1 October 2026, $2.07 on 14 October 2026 and $2.02 on 26 October 2026 (Morningstar). The 14-day relative strength index was 35.6 on 27 October 2026, below the midpoint of 50 but above the 30 level that marks heavily sold shares.

The nearest resistance is the $2.25 level from the earlier note. The $1.98 52-week low and the $1.63 conversion floor sit below the market. Deutsche Bank's target was adjusted on 27 October 2026 according to a company-news headline; the new figure was not available. Its last confirmed action was a cut to $5 from $7 with a Hold rating on 20 March 2026, citing dilution.

Crowding evidence points the other way from a squeeze. Equity supply is registered for resale, a convertible facility is partly drawn, and the shares are 66.5% under their 52-week high. No SEC filings were reported after 15 October 2026.

Catalysts, next 30 days

• ~12 November 2026 (est.): third-quarter 2026 results. Earnings Whispers lists 9 November 2026 and 12 November 2026, and AJ Bell lists 13 November 2026; the company has not confirmed a date. The report updates capital spending, liquidity, share count, the $2.93 billion Phase 1 estimate and the late-2027 completion date.
• Ongoing: Yorkville conversions and at-the-market sales. Share-count changes appear in filings and in the quarterly report.
• ~31 December 2026 (est.): power energization target. The company targets Thacker Pass power energization in the fourth quarter of 2026. The milestone shows whether the schedule behind late-2027 completion holds.

What would change the view

The case ends if the company raises the $2.93 billion Phase 1 estimate or moves mechanical completion beyond late 2027. Either result would show that the funding and schedule behind the project case have slipped.

On price, a daily close below $1.63 would fire the invalidation. That is the floor price in the Yorkville conversion formula and sits under every close in the current slide.

A move back above $2.25 on rising lithium carbonate prices, with a third-quarter report that holds the cost and schedule, would weaken the bear case. A report showing heavy Yorkville conversions at prices near the floor would confirm it.

What it trades with

Lithium Americas follows lithium carbonate prices, shown by the 12 October 2026 futures drop and the share slide that followed. Albemarle shares reacted to the same futures move, according to GuruFocus. A 22 October 2026 article on lithium's supply gap and Albemarle's domestic position shows attention on US lithium names, yet LAC has no producing asset. Federal policy and General Motors, both warrant holders, link the shares to US critical-materials policy and electric-vehicle demand.